Lifecare ASA

Lifecare ASA: New share capital registered

Reference is made to the stock exchange announcement by Lifecare ASA (the

"Company") on 12 November 2025 regarding the resolution by the Extraordinary

General Meeting held on the same date to reduce the par value of the Company's

shares to NOK 0.10, in order to facilitate the subscription of shares and

exercise of warrants in connection with the contemplated partially

underwritten rights issue announced by the Company on 22 October 2025.

The share capital reduction has now been registered with the Norwegian

1,906,097.30 divided into 19,060,973 shares, each with a par value of NOK

0.10.

About us

Lifecare ASA is a medical sensor company developing technology for sensing and

monitoring of various body analytes. Lifecare's focus is to bring the next

generation of Continuous Glucose Monitoring systems to market. Lifecare

enables osmotic pressure as sensing principle. Lifecare's sensor technology is

suitable for identifying and monitoring the occurrence of a wide range of

analytes and molecules in the human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, [email protected], +47 40 05 90 40

Renete Kaarvik, CFO, [email protected], +47 94 83 82 42

This information is subject to disclosure under the Norwegian Securities

Trading Act, §5-12. The information was submitted for publication, through the

agency of the contact persons set out above, at 2025-12-31 10:40 CET.

AI Terminal